Chronic Myelod Leukemia Registry at Asan Medical Center

Asan Medical Center

Status: Terminated

Conditions: Leukemia, Chronic Myeloid; Myeloid Leukemia, Chronic, Chronic Phase; Myeloid Leukemia, Chronic, Accelerated Phase

Treatments: Other: Diagnosed as CML

Study type: Observational

Funder types: Other

Identifiers

NCT01761695

AMC-HEMREG-CML

Details and patient eligibility

About

The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for chronic myeloid leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.

Full description

1. Acquisition of informed concent form

2. Data acquisition from medical record including

   • demographic / disease-associated factors
   • details of treatment, and its results
   • complications during treatment
   • genetic data
   • survival outcome (upto 30 years)

3. Accumulation of data for 30 years

4. Use of data for other retrospective analysis (including Asan Medical center Cell Banking basic data)

Enrollment: 100 patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who are diagnosed and/or treated as chronic myeloid leukemia at Asan Medical Center
• 15 years of age and over
• All patients who give written consent according to guidelines at Asan Medical Center committee on human research

Exclusion criteria

• Patients who refuse to give consent to registering

Trial design

100 participants in 4 patient groups

CML CP

Description:

Diagnosed as CML with chronic phase

Treatment:

Other: Diagnosed as CML

CML AP

Description:

Diagnosed as CML with accelerated phase

Treatment:

Other: Diagnosed as CML

CML BC

Description:

Diagnosed as CML with blast crisis

Treatment:

Other: Diagnosed as CML

CML other

Description:

Diagnosed as CML, which is not included in any of other category

Treatment:

Other: Diagnosed as CML